Active Seat System - 6-Cell Alternating Cushion for Maximum Pressure Relief. - CareSupplies.com Medical Equipment
search
  • Active Seat System - 6-Cell Alternating Cushion for Maximum Pressure Relief. - CareSupplies.com Medical Equipment
  • Active Seat System - 6-Cell Alternating Cushion for Maximum Pressure Relief. - CareSupplies.com Medical Equipment
  • Active Seat System - 6-Cell Alternating Cushion for Maximum Pressure Relief. - CareSupplies.com Medical Equipment

Active Seat System - 6-Cell Alternating Cushion for Maximum Pressure Relief.

  • 6-Cell Active Alternating Cushion with Foam Base - the Active Seat System uses 6 alternating air cells mounted on an integrated foam base, providing dynamic alternating pressure redistribution for very high-risk seated pressure care; the foam base beneath the air cells prevents the resident from contacting the seat surface through a deflated cell during the alternating cycle, maintaining a functional support surface throughout the full cycle range; the 6-cell configuration provides alternating offloading at the primary seated pressure sites across a compact 400 x 430 x 90mm footprint.
  • Compatible with Both Harvest 1 and Harvest 250 Pumps - the Active Seat System accepts both the Harvest 1 (manual dial) and Harvest 250 (digital) pumps, providing greater procurement flexibility than the Blenheim cushion which requires the Harvest 250 specifically; the Harvest 1 provides basic alternating pressure therapy; the Harvest 250 adds digital therapy modes including CLP and seated mode; pump selection should be based on the clinical needs of the resident and the existing pump inventory at the care setting; the pump must be secured safely adjacent to the chair with tubing managed to prevent falls risk.
  • For Residents Who Prefer Seated to Bed-Based Care - the Active Seat System is designed for residents who do not wish to spend extended periods in bed or who cannot comfortably remain in bed for the full duration of their waking period; by providing active alternating pressure care in the seated position, the system supports a care plan that uses the bed for overnight rest and the active seat cushion for daytime seated periods, extending active pressure therapy coverage across the full 24-hour period when paired with an active alternating mattress.
  • 158kg SWL - 400x430x90mm - MDR Class IIa - Pairs with Hampton II - SWL 158kg (25 stone); four pump and system options available (NCL-HH20.P1, .P250, .HPU1, .HPU250); zipped water-resistant 4-way stretch cover; non-slip base; pairs with Hampton II mattress; MDR 2017/745 Class IIa active medical device; SWL verified per MHOR 1992; occupational therapist assessment required per NICE CG179.
Product Options: Active Seat Cushion System with Harvest 250 Pump

Active Seat System - 6 Alternating Cells - Foam Base - Harvest 1 or 250 - 158kg SWL - Very High Risk

The Active Seat System (NCL-HH20) provides 6-cell alternating pressure redistribution for very high-risk seated pressure care, with an integrated foam base that maintains support when cells are in the deflation phase. Compatible with both Harvest 1 and Harvest 250 pumps. Available in four configurations. SWL 158kg. 400 x 430 x 90mm. Pairs with Hampton II mattress for 24-hour active pressure care. MDR 2017/745 Class IIa active medical device.

Specifications

SpecificationDetail
Active Cells6 alternating air cells with foam base
Dimensions400 x 430 x 90mm
Safe Working Load158kg (25 stone)
Cover4-way stretch zipped water-resistant
BaseNon-slip
NCL-HH20.P1Cushion only - Harvest 1 pump
NCL-HH20.P250Cushion only - Harvest 250 pump
NCL-HH20.HPU1Complete system with Harvest 1 pump
NCL-HH20.HPU250Complete system with Harvest 250 pump
Paired MattressHampton II (NCL-HAMHAMP005)
Clinical Risk LevelVery high risk per NICE CG179
Regulatory StatusMDR 2017/745 Class IIa active medical device

Regulatory Compliance

The Active Seat System is a Class IIa active medical device under MDR 2017/745. Clinical selection requires occupational therapist assessment per NICE CG179 confirming very high-risk seating need. SWL of 158kg must be verified per MHOR 1992. The pump must be confirmed operational and secured safely; tubing must be managed to prevent trip hazards adjacent to the chair. The pump and cushion variant codes must be confirmed compatible before issue; the P1 cushion variant must not be connected to a Harvest 250 pump and vice versa. Equipment register records including both pump and cushion serial numbers and MDR conformity documentation must be maintained for CQC Regulation 12 compliance.

Frequently Asked Questions

What is the clinical difference between the Active Seat System (6-cell) and the Blenheim Active Seat Cushion (9-cell)?

Both are active alternating seat cushions for very high-risk seating pressure care, but they differ in cell count, pump compatibility, and overall depth. The Active Seat System uses 6 alternating cells on a foam base at 400 x 430 x 90mm and accepts both the Harvest 1 and Harvest 250 pumps, providing procurement flexibility and a deeper profile with the foam base that eliminates the risk of cell deflation contacting the seat surface. The Blenheim uses 9 alternating cells without a separate foam base at 460 x 460 x 60mm and requires the Harvest 250 specifically; the higher cell count provides more granular alternating coverage of the seated contact zone but at a shallower profile. The clinical selection is based on the resident's seated anatomy and pressure care needs: a resident where complete ischial and sacral coverage across a wider zone is the priority may benefit from the Blenheim's 9-cell arrangement; a resident where the foam base failsafe function and dual-pump compatibility are clinically or operationally important may be better served by the Active Seat System. The occupational therapist should make this determination based on the individual assessment and the care setting's existing pump infrastructure.

How should the pump and tubing be managed to prevent trip hazards when using an active seat cushion in a care home?

An active seat cushion requires the pump to run continuously during use, which means the pump and its power cable and the tubing connecting the pump to the cushion are all present at the chair position throughout the period the cushion is in use. The pump should be secured to the chair frame using a purpose-designed pump bag or bracket where available, or positioned on a stable surface immediately adjacent to the chair at floor level. The tubing should be routed along the chair frame or taped to prevent it from lying across the floor in areas where carers or the resident may walk; a tubing loop left at floor level between the pump and the cushion is a significant trip hazard. The power cable from the pump to the mains outlet should be routed along the baseboard or secured with cable clips, not laid across the room or in doorways. The care team must complete a specific risk assessment for the seated pump configuration before the cushion is issued; this assessment must address trip hazard routing, power outlet proximity, and the resident's ability to move the pump accidentally during repositioning.

NCL-HH20.P1